Property transfer records show that Catalent bought the parcels on Oct. A spokeswoman told The Herald-Times only that the company “continues to invest in our world-class operations in Bloomington to expand capabilities.” The company declined to provide details about its plans for the property. Drug maker Catalent has bought three parcels of land just south of its Bloomington plant for nearly $1.2 million.